DH-JH rearrangements of the Ig heavy-chain gene (IGH) occur early during B-cell development. Consequently, they are detected in precursor-B-cell acute lymphoblastic leukemias both at diagnosis and relapse. Incomplete DJH rearrangements have also been occasionally reported in mature B-cell lymphoproliferative disorders, but their frequency and immunobiological characteristics have not been studied in detail. We have investigated the frequency and characteristics of incomplete DJH as well as complete VDJH rearrangements in a series of 84 untreated multiple myeloma (MM) patients. The overall detection rate of clonality by amplifying VDJH and DJH rearrangements using family-specific primers was 94%. Interestingly, we found a high frequency (60%) of DJH rearrangements in this group. As expected from an immunological point of view, the vast majority of DJH rearrangements (88%) were unmutated. To the best of our knowledge, this is the first systematic study describing the incidence of incomplete DJH rearrangements in a series of unselected MM patients. These results strongly support the use of DJH rearrangements as PCR targets for clonality studies and, particularly, for quantification of minimal residual disease by real-time quantitative PCR using consensus JH probes in MM patients. The finding of hypermutation in a small proportion of incomplete DJH rearrangements (six out of 50) suggests important biological implications concerning the process of somatic hypermutation. Moreover, our data offer a new insight in the regulatory development model of IGH rearrangements.
Introduction
During B-cell differentiation the V, D and J gene segments of the Ig gene locus are rearranged in an ordered fashion for the generation of the primary Ig repertoire. Ig heavy-chain (IGH) rearrangement precedes Ig light chain (IGL) rearrangement and, in particular, D to JH joining precedes V to DJH joining. 1, 2 These rearrangements are mediated by recombination signal sequences (RSS) flanking each gene segment. After a functional VDJH rearrangement, the other IGH allele is generally excluded. [3] [4] [5] [6] Two models have been proposed for the mechanism of allelic exclusion: the stochastic model supposes that the rearrangement is imprecise and, consequently, the chances of producing an in-frame VDJH at both alleles is low because the process itself is prone to error; 3 on the other hand, the regulatory model states that rearrangement at one allele may affect rearrangement at the other, probably through m-heavy-chainderived signals. 1, [4] [5] [6] According to the regulatory model, there are three possible IGH gene configurations in a given mature Ig(+)B cell: first, both IGH alleles have undergone complete VDJH rearrangement, one productive and one nonproductive in the majority of cases, although the lack of allelic exclusion in a small group of B-cell chronic lymphocytic leukemias (B-CLL) has been demonstrated; 7 secondly, one productive VDJH allele and the other an incomplete DJH rearrangement; and finally, one productive VDJH rearrangement and the second allele in germline configuration. So far, the frequencies of these different IGH gene configurations have not been reported for patients suffering from mature B-cell malignancies, although they have been described in B-cell lines and normal B lymphocytes 1 and, more recently, in IGH negative MM. 8 Multiple myeloma (MM) is the most mature B-cell malignancy characterized by the accumulation of clonal plasma cells in the bone marrow (BM) producing high amounts of monoclonal Ig. The origin of the neoplastic cells in MM is thought to be a postfollicular memory B cell, although there has been a great deal of debate regarding the origin of the clonogenic tumor cell, possibly of a less mature origin or even from a stem cell. [9] [10] [11] Evidence of a postfollicular origin comes from the Ig gene configuration in plasma cells, that are found to be somatically hypermutated, with no intraclonal variation and classswitched. 9, 12 These hypermutated IGH genes have hampered the molecular diagnosis of clonality by PCR because of the frequent occurrence of mismatches between the VH or JH segments and the corresponding primers. 13 Consequently, realtime quantitative-PCR (RQ-PCR) analyses of the clonogenic VDJH rearrangements for the detection of minimal residual disease (MRD) appears to be much more complicated when applied to postfollicular B-cell malignancies than in malignancies of immature B cells, [14] [15] [16] since it requires the design of specific probes and primers to avoid the mismatches caused by somatic hypermutation (SH), 17 which is significantly more expensive and time-consuming than using consensus probes.
In the present paper, we have studied the frequency and characteristics of both complete VDJH and incomplete DJH rearrangements in a series of 84 untreated MM patients. We have found an unexpectedly high frequency (60%) of incomplete DJH rearrangements, without SH in the vast majority of cases. These results favor the use of DJH rearrangements as PCR targets for clonality studies, especially to monitor minimal residual disease by RQ-PCR, using consensus JH probes in MM patients. In addition, the data presented here offers new insights into the regulatory developmental model of IGH rearrangements.
Methods

MM patients
Cell samples were obtained from BM aspirates of 84 untreated MM patients whose diagnosis was made according to the criteria of the Chronic Leukemia Myeloma Task Force 18 and confirmed by immunophenotypical criteria. 19 The monoclonal Genomic DNA preparation, PCR amplification and heteroduplex analysis High molecular weight DNA was isolated by standard proteinase K digestion, phenol-chloroform extraction and ethanol precipitation. 20 For amplification of complete VDJH rearrangements, three different sets of family-specific primers and one JH consensus primer were used in three different multiplexed PCR reactions covering the three framework regions(FRs) (ie FR1, FR2 and FR3). Amplification of incomplete DJH rearrangements was performed in two different reactions using family-specific primers for DH1-DH6 and DH7 families, respectively, together with the consensus JH primer ( Figure 1 ). All primers had been newly designed during the BIOMED-2 Concerted Action 'PCR-based clonality studies for early diagnosis of lymphoproliferative disorders' (PL96-3936) (van Dongen JM et al. Blood 2001; 98:129). All reactions were carried out in 50 ml containing 0.1 mg DNA samples and 10 pmol of each primer.
For heteroduplex analysis, PCR products were denatured at 941C for 10 min and subsequently cooled at 41C for 60 min to induce duplex formation. 20, 21 The hetero and/or homoduplexes generated were immediately loaded on a 10% nondenaturing polyacrylamide gel in 1x Tris-acetate-EDTA buffer, run at room temperature, and visualized by ethidium bromide staining. The presence of one or two clear bands within the expected size indicated clonality, while polyclonal samples appeared as a rough smear in the gel. 20, 21 Sequencing and analysis of Ig genes PCR products were eluted from the polyacrylamide gels and directly sequenced in an automated ABI 377 DNA sequencer using Big-Dye terminators (Applied Biosystems, Foster City, CA, USA). In order to avoid nucleotide misinterpretations because of Taq error, all products were sequenced at least twice from different PCR reactions using 5 0 VH/DH and/or 3 0 JH primers. Germline VH, DH and JH segments from complete VDJH rearrangements were identified by comparison with the V base 22 and IGMT database 23 using on-line DNAPLOT (MRC Center for Protein Engineering). DH and JH germline segments from incomplete DJH rearrangements were identified using BLAST search in the DH-JH germline locus sequence (accession number EMB/X97051).
Sequences containing more than 2% deviation from the germline sequence were considered as somatically mutated rather than genomic polymorphisms. In such cases, a binomial distribution model 24 was applied in order to discriminate replacement (R) and silent (S) mutations derived from antigen selection or acquired by random choice.
Results
Detection of clonal rearrangements in MM by PCR
The overall detection rate of clonality by amplifying VDJH and DJH rearrangements was 94% (79/84). VDJH rearrangements were detected in 73 out of 84 patients (84%) and DJH rearrangements were seen in 50/84 patients (60%). In six out of the 11 patients in whom no VDJH product was obtained, DJH PCR showed a monoclonal band ( Table 1) . Analysis of the clinical data in these patients, with only DJH rearrangement detected by PCR, showed that three of them belonged to the group of 11 Bence Jones (BJ) MM patients. VDJH rearrangements on both alleles were detected in only four of the 84 patients (5%).
SH in complete VDJH
All VH segments contained more than 2% deviation from the germline gene compared with the molecular databases (median VDJH amplification is carried out in three separate reactions containing the JH consensus primer and a combination of the different VH family-specific primers for FR1, FR2 and FR3 regions (tubes 1, 2 and 3, respectively). DJH amplification is performed in two separate reactions containing the JH consensus primer combined with the DH family-specific primers (DH1-DH6 in tube 1 and DH7 in tube 2).
Incomplete DJH rearrangements in multiple myeloma D González et al 7.2%;. range 2.2-20.8) ( Table 1 ). The types of mutations were predominantly single-base substitutions, although in four out of the 73 patients, insertions or deletions were also found. In addition, as described elsewhere, transitions were found more often than transversions affecting purines rather than pyrimidines. Analysis of mutations in the 73 patients with clonal VDJH rearrangement, in accordance with the binomial distribution model, 24 revealed 24 patients (33%) displaying SH resembling antigen-driven response. Distribution of R and S mutations in these rearrangements significantly differed from that predicted by random choice in both CDRs and FRs regions (Po0.05). We found 25 additional samples with significant cluster of R and S mutations in only CDRs or FRs regions. In particular, we found 16 samples (22%) with a lower R:S ratio at the FR regions, and nine (12%) containing a higher R:S ratio at the CDRs with significant P values (o0.05). Thus, taking all data together, we found a pattern of antigen-driven SH in 49 out of 73 (67%) MM patients.
Lack of mutations in DJH rearrangements
Sequence analysis reveled that 44 out of 50 (88%) DJH rearrangements were completely unmutated or showed at least 98% homology with the closest germline DH sequences. In the remaining six cases, the mean of mutations in DJH rearrangements was 5% ranging from 2.3 to 9% (Table 1) . These mutations resemble those from normal SH in complete VDJH rearrangements, since they are point mutations rather than insertion or deletions, transitions are preferred over transversions and purines over pyrimidines. In contrast to SH in VDJH rearrangements, we did not find mutations in the JH region in any of the DJH rearrangements, including the six patients with somatically mutated DJH rearrangements. 
N-region addition and exonuclease activity in VDJH and DJH rearrangements
Upon analyzing the number of N nucleotides and the exonuclease activity at the DH-JH junctions of complete and incomplete rearrangements, no significant differences between either subgroup were found ( Table 2) . Analysis of VH-DH junction in complete rearrangements showed similar levels of N nucleotides as in DH-JH junctions, as well as similar exonuclease activity on the DH side. Exonuclease activity at the VH side was extremely low, with 67 out of 73 patients in this series retaining the complete VH sequence.
Clinical correlations
Finally, we evaluated whether the load of somatic mutations, the presence of incomplete DJH rearrangements, and VH or DH gene segment usage correlated with the prognosis of the MM patients. Our data suggest that, contrary to findings in B-CLL, the presence SH as well as the particular VH or DH gene segments usage in IGH rearrangements do not correlate with patient outcome in MM (data not shown) . However, since the present series of MM patients contains an heterogeneous population regarding both age and type of therapy, we cannot rule out the possibility that some clinical correlation could be achieved by analyzing different, more homogeneous, series of MM patients.
Discussion
Clonality assessment by PCR in mature B-cell malignancies have been hampered by the physiological accumulation of somatic mutations in the IGH genes, which lead to mismatches between the VH and JH sequences and the corresponding consensus primers. 13 In these study, we demonstrate an overall detection rate of clonality of 94% in MM patients using this novel approach of combining VDJH and DJH PCR for the amplification of IGH genes. This incidence is significantly higher than with our previous in-home strategy that only used consensus primers complementary to FR2 and FR3 regions (79% of MM patients). 13 Interestingly, 60% of the patients contained DJH rearrangements, including six out of 11 patients that lacked VDJH amplification. Three of these VDJH-negative patients were BJ-MM. Accordingly, Szczepanski et al 8 demonstrated that, in five out of 12 IGH-negative MM patients, the lack of the functional VDJH rearrangement was accompanied by an incomplete DJH rearrangement in the other allele. 8 The more plausible explanation for the lack of VDJH amplification in the remaining patients is the existence of a high level of SH in the functional IGH allele, reducing priming efficiency.
We have found that two-thirds of MM patients display a pattern of SH in VDJH rearrangements compatible with antigen stimulation. Since the clonogenic cell in MM is thought to be a mature antigen-experienced cell, it should have passed through the follicle and consequently should have undergone the germinal center reaction that includes SH. However, a subset of MM patients (33%) does not display a pattern of antigendriven hypermutation in IGH genes. 10 Several alternative hypotheses have been proposed for these cases. First, it has been demonstrated that IGLs can also be the target for antigen affinity maturation 25, 26 instead of IGH. Second, certain R mutations in CDRs or FRs, as well as the charge, composition and structure of the IGH and IGL CDR3 -the regions in closest contact with antigen -can increase the antibody affinity more than 10-fold. [27] [28] [29] It is well demonstrated that SH is transcription-coupled and occurs in a region spanning 1.5-2 kb from the promoter (ie from 300 bp 5 0 VH to JH-Cm intron), requiring both the enhancer and the promoter to carry out the process. [30] [31] [32] [33] Thus, the lack of the VH with its corresponding IGH gene leader and promoter regions should avoid the SH mechanism, which would explain why most of the DJH rearrangements found in our series were unmutated. However, we have found 12% of the DJH rearrangements containing SH. To the best of our knowledge, this is the first report that describes SH in incomplete DJH rearrangements, probably because DJH rearrangements have only been extensively studied in immature pre-B cells 34 and precursor-B-ALL. 35 The transcription of DJH rearrangements in pre-B cells have been reported. 34, 36 In this sense, if DJH transcription also occurs in mature B cells during germinal center reactions, it could lead to SH in some particular cases by interacting with one of the 3' IGH enhancers. Assuming this hypothesis, one would expect that SH in DJH is associated with particular DH segments containing promoter regions capable of interacting with the enhancers. However, in our series we found that those DJH containing hypermutation are also represented in the nonmutated DJH rearrangements (data not shown).
It has been reported that a high load of somatic mutations in IGH genes is associated with favorable prognosis in B-CLL. 37 Therefore, we evaluated whether the load of somatic mutations and the presence of incomplete DJH rearrangements correlated with the prognosis of the MM patients, but we did not find any evidence that the parameters significantly influenced outcome. Therefore, we should conclude that, in contrast to B-CLL, the presence of SH have no clinical prognostic implications in MM patients.
In the last 4 years, RQ-PCR has become an attractive and useful approach for the detection of MRD in B-cell malignancies, mainly because of the utilization of consensus probes in the JH region avoiding the synthesis of allele-specific probes (ASO probes) for each patient, which is very expensive and time-consuming. 16 JH consensus probes have been successfully applied in precursor-B-ALL and the subset of B-CLL without SH. 14, 15, 38 Unfortunately, this approach is less optimal for MRD analysis of postgerminal-center-derived B-cell malignancies with a high level of SH, because of mismatches between the probes/primers and the mutated VDJH rearrangement. 17 However, here we show that 60% of MM patients display an incomplete tumor-specific DJH rearrangement, and that the vast majority of them (88%) do not have SH. Furthermore, in all DJH rearrangements with deviations from the published germline sequences, the mutations were clustered in the DH gene segments and no mutations were observed in the rearranged JH segments. Consequently, the DJH rearrangements in MM are Indicated as number of germline nucleotides removed.
Incomplete DJH rearrangements in multiple myeloma D González et al excellent RQ-PCR targets for monitoring MRD during the disease course. This is particularly important for MM patients undergoing hematopoietic stem cell transplantation. Upon analyzing the N-region composition, we did not find significant differences between VDJH and DJH rearrangements. These results suggest that DJH rearrangements may occur on both alleles at the same time during early B-cell development (ie at the pro-B stage), making both alleles accessible for completion of the V-DJH rearrangement at the pre-BI stage. 39, [4] [5] [6] The regulatory model of allelic exclusion presumes that rearrangement of one functional VDJH allele prevents subsequent rearrangement of the 'secondary' nonrearranged (germline) or incomplete DJH rearranged allele. 1, 5, 6 In a m-IGH chain transgene model, it has indeed been shown that suppression of further V-DJH rearrangements occurs, 40 which was associated with an extended period of DH-JH rearrangement. 4 . According to this model, the percentage of mature Ig-producing B cells with the VDJH/DJH genotype has been estimated to be around 50%. However, in the study by Alt et al, 1 they found that only 30% of myeloma cell lines contained DJH rearrangements. In contrast, in the present study we have demonstrated the presence of incomplete DJH rearrangements in 60% of MM patients, which is slightly higher than the predicted value for Ig-producing B cells. In conclusion, the high incidence of unmutated DJH rearrangements strongly support their use as preferential targets for clonality diagnosis and, specially for RQ-PCR-based MRD detection using consensus probes in MM. Furthermore, our results offer new insights in the process of SH and the regulatory model of IGH rearrangement during B-cell development.
